News Article

Swiss hearing health leader Sonova has bolstered its digital therapeutics portfolio with the acquisition of SilentCloud, a clinically validated tinnitus management app serving over 740m global sufferers of the condition.

Sonova’s acquisition signals a strategic shift from hardware-centric revenue toward recurring software-enabled services, with SilentCloud’s cloud-based platform creating opportunities for data-driven care personalisation and subscription models.

For operators, this underscores the growing trend to integrate digital therapeutics into traditional MedTech portfolios, as reimbursement frameworks evolve to recognise outcomes-based value.

Competitors like GN Store Nord and Cochlear may look to accelerate similar ecosystem plays, given Sonova’s solutions are available across six markets (U.S., Switzerland, Belgium, Italy, Ireland, Luxembourg).

Financial terms remain undisclosed.